So, about that Pain and Policy Group at the University of Wisconsin – the one that allegedly received $1.6 million from OxyContin maker Purdue in exchange for lobbying for the de-regulation of narcotic pain medicine? After an article in the Milwaukee Journal Sentinel/MedPage blew its cover, the University’s chancellor was bombarded with requests to shut the group down. Guess what? The chancellor now claims the group no longer accepts funding from industry involved in the sale and marketing of opioids – a decision that was *supposedly* made before the media expose.
Doubts abound – but at least it’s one less outlet to be used by Purdue as a sounding board.
Read the chancellor’s response to Pete Jackson, the president of Advocates for the Reform of Prescription Opioids, here.